MedPath

Teva Pharmaceuticals Usa

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Ondansetron HCl Orally Disintegrating Tablets Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2009-07-08
Last Posted Date
2024-08-21
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
24
Registration Number
NCT00934180
Locations
🇺🇸

Novum Pharmaceutical Research Services, Houston, Texas, United States

Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2009-07-08
Last Posted Date
2024-08-21
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
24
Registration Number
NCT00934921
Locations
🇺🇸

Novum Pharmaceutical Research Services, Houston, Texas, United States

Mycophenolate Mofetil 250 mg Capsules Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2009-06-01
Last Posted Date
2024-08-19
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
53
Registration Number
NCT00911274
Locations
🇺🇸

Cedra Clinical Research, LLC, Austin, Texas, United States

Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2009-06-01
Last Posted Date
2024-08-19
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
60
Registration Number
NCT00910663
Locations
🇺🇸

Cedra Clinical Research, LLC, Austin, Texas, United States

Ursodiol 500 mg Tablets Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2009-05-28
Last Posted Date
2024-08-19
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
92
Registration Number
NCT00909753
Locations
🇨🇦

Pharma Medica Research Inc., Toronto, Ontario, Canada

Ursodiol Tablets 500 mg Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2009-05-28
Last Posted Date
2024-08-19
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
80
Registration Number
NCT00909610
Locations
🇨🇦

Pharma Medica Research Inc., Toronto, Ontario, Canada

Mycophenolate Mofetil Tablets Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2009-05-25
Last Posted Date
2024-08-19
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
40
Registration Number
NCT00907907
Locations
🇨🇦

Pharma Medica Research Inc., Toronto, Ontario, Canada

Mycophenolate Mofetil Tablets Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2009-05-25
Last Posted Date
2024-08-19
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
40
Registration Number
NCT00908128
Locations
🇨🇦

Pharma Medica Research Inc., Toronto, Ontario, Canada

Topiramate 25 mg Tablets Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2009-05-20
Last Posted Date
2024-08-19
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
30
Registration Number
NCT00905606
Locations
🇨🇦

Anapharm Inc., Sainte-Foy, Quebec, Canada

Topiramate 25 mg Tablets Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2009-05-20
Last Posted Date
2009-09-23
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
24
Registration Number
NCT00905567
Locations
🇨🇦

Anapharm Inc., Sainte-Foy, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath